Randomized, Double-Blind, Placebo-Controlled Trial of Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for the Treatment of Idiopathic Pneumonia Syndrome After Allogeneic Stem Cell Transplantation: BMT CTN Protocol

Submitted by ctuttle on
Go back to Resources

Randomized, Double-Blind, Placebo-Controlled Trial of Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for the Treatment of Idiopathic Pneumonia Syndrome After Allogeneic Stem Cell Transplantation: BMT CTN Protocol

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Randomized Trial of the ForeseeHome Monitoring Device for Early Detection of Neovascular Age-Related Macular Degeneration. The HOme Monitoring of the Eye (HOME) Study Design - HOME Study Report Number 1

Submitted by ctuttle on
Go back to Resources

Randomized Trial of the ForeseeHome Monitoring Device for Early Detection of Neovascular Age-Related Macular Degeneration. The HOme Monitoring of the Eye (HOME) Study Design - HOME Study Report Number 1

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Racial/Ethnic Differences in Clinical Trial Enrollment, Refusal Rates, Ineligibility, and Reasons for Decline Among Patients at Sites in The National Cancer Institute's Community Cancer Centers Program

Submitted by ctuttle on
Go back to Resources

Racial/Ethnic Differences in Clinical Trial Enrollment, Refusal Rates, Ineligibility, and Reasons for Decline Among Patients at Sites in The National Cancer Institute's Community Cancer Centers Program

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Phase II Randomized, Double-Blinded Comparison of a Single High Dose (5×10(8) TCID 50) of Modified Vaccinia Ankara Compared to a Standard Dose (1×10(8) TCID50) in Healthy Vaccinia-Naïve Individuals

Submitted by ctuttle on
Go back to Resources

Phase II Randomized, Double-Blinded Comparison of a Single High Dose (5×10(8) TCID 50) of Modified Vaccinia Ankara Compared to a Standard Dose (1×10(8) TCID50) in Healthy Vaccinia-Naïve Individuals

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources